Report Detail

Request for Sample of this report

Pharma & Healthcare Global IL-23 Receptor Antagonist Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4749420
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 108 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global IL-23 Receptor Antagonist market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
IL-23 receptor antagonists are a class of biologic drugs that target the IL-23 pathway,specifically by blocking the IL-23 receptor.By inhibiting the IL-23 receptor,these antagonists disrupt the signaling cascade that leads to the production of pro-inflammatory cytokines,which are implicated in the chronic inflammation characteristic of these conditions.
This report is a detailed and comprehensive analysis for global IL-23 Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IL-23 Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-23 Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-23 Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-23 Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IL-23 Receptor Antagonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IL-23 Receptor Antagonist market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Janssen Pharmaceuticals, Sun Pharma, Almirall, China Medical System, AbbVie Biotechnology, Eli Lilly, Teva, Amgen, Samsung Bioepis, Sandoz, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IL-23 Receptor Antagonist market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ustekinumab
Briakinumab
Tildrakizumab
Guselkumab
Risankizumab
Mirikizumab
Other
Market segment by Application
Crohn's Disease
Plaque Psoriasis
Psoriatic Arthritis
Other
Major players covered
Janssen Pharmaceuticals
Sun Pharma
Almirall
China Medical System
AbbVie Biotechnology
Eli Lilly
Teva
Amgen
Samsung Bioepis
Sandoz
Biocon Biologics
Celltrion
Qyuns Therapeutics
Bio-Thera Solutions
Huadong Medicine
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IL-23 Receptor Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IL-23 Receptor Antagonist, with price, sales quantity, revenue, and global market share of IL-23 Receptor Antagonist from 2021 to 2026.
Chapter 3, the IL-23 Receptor Antagonist competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IL-23 Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IL-23 Receptor Antagonist market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IL-23 Receptor Antagonist.
Chapter 14 and 15, to describe IL-23 Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global IL-23 Receptor Antagonist Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Ustekinumab
    • 1.3.3 Briakinumab
    • 1.3.4 Tildrakizumab
    • 1.3.5 Guselkumab
    • 1.3.6 Risankizumab
    • 1.3.7 Mirikizumab
    • 1.3.8 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global IL-23 Receptor Antagonist Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Crohn's Disease
    • 1.4.3 Plaque Psoriasis
    • 1.4.4 Psoriatic Arthritis
    • 1.4.5 Other
  • 1.5 Global IL-23 Receptor Antagonist Market Size & Forecast
    • 1.5.1 Global IL-23 Receptor Antagonist Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global IL-23 Receptor Antagonist Sales Quantity (2021-2032)
    • 1.5.3 Global IL-23 Receptor Antagonist Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Janssen Pharmaceuticals
    • 2.1.1 Janssen Pharmaceuticals Details
    • 2.1.2 Janssen Pharmaceuticals Major Business
    • 2.1.3 Janssen Pharmaceuticals IL-23 Receptor Antagonist Product and Services
    • 2.1.4 Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Janssen Pharmaceuticals Recent Developments/Updates
  • 2.2 Sun Pharma
    • 2.2.1 Sun Pharma Details
    • 2.2.2 Sun Pharma Major Business
    • 2.2.3 Sun Pharma IL-23 Receptor Antagonist Product and Services
    • 2.2.4 Sun Pharma IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sun Pharma Recent Developments/Updates
  • 2.3 Almirall
    • 2.3.1 Almirall Details
    • 2.3.2 Almirall Major Business
    • 2.3.3 Almirall IL-23 Receptor Antagonist Product and Services
    • 2.3.4 Almirall IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Almirall Recent Developments/Updates
  • 2.4 China Medical System
    • 2.4.1 China Medical System Details
    • 2.4.2 China Medical System Major Business
    • 2.4.3 China Medical System IL-23 Receptor Antagonist Product and Services
    • 2.4.4 China Medical System IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 China Medical System Recent Developments/Updates
  • 2.5 AbbVie Biotechnology
    • 2.5.1 AbbVie Biotechnology Details
    • 2.5.2 AbbVie Biotechnology Major Business
    • 2.5.3 AbbVie Biotechnology IL-23 Receptor Antagonist Product and Services
    • 2.5.4 AbbVie Biotechnology IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AbbVie Biotechnology Recent Developments/Updates
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly IL-23 Receptor Antagonist Product and Services
    • 2.6.4 Eli Lilly IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eli Lilly Recent Developments/Updates
  • 2.7 Teva
    • 2.7.1 Teva Details
    • 2.7.2 Teva Major Business
    • 2.7.3 Teva IL-23 Receptor Antagonist Product and Services
    • 2.7.4 Teva IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Teva Recent Developments/Updates
  • 2.8 Amgen
    • 2.8.1 Amgen Details
    • 2.8.2 Amgen Major Business
    • 2.8.3 Amgen IL-23 Receptor Antagonist Product and Services
    • 2.8.4 Amgen IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Amgen Recent Developments/Updates
  • 2.9 Samsung Bioepis
    • 2.9.1 Samsung Bioepis Details
    • 2.9.2 Samsung Bioepis Major Business
    • 2.9.3 Samsung Bioepis IL-23 Receptor Antagonist Product and Services
    • 2.9.4 Samsung Bioepis IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Samsung Bioepis Recent Developments/Updates
  • 2.10 Sandoz
    • 2.10.1 Sandoz Details
    • 2.10.2 Sandoz Major Business
    • 2.10.3 Sandoz IL-23 Receptor Antagonist Product and Services
    • 2.10.4 Sandoz IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sandoz Recent Developments/Updates
  • 2.11 Biocon Biologics
    • 2.11.1 Biocon Biologics Details
    • 2.11.2 Biocon Biologics Major Business
    • 2.11.3 Biocon Biologics IL-23 Receptor Antagonist Product and Services
    • 2.11.4 Biocon Biologics IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Biocon Biologics Recent Developments/Updates
  • 2.12 Celltrion
    • 2.12.1 Celltrion Details
    • 2.12.2 Celltrion Major Business
    • 2.12.3 Celltrion IL-23 Receptor Antagonist Product and Services
    • 2.12.4 Celltrion IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Celltrion Recent Developments/Updates
  • 2.13 Qyuns Therapeutics
    • 2.13.1 Qyuns Therapeutics Details
    • 2.13.2 Qyuns Therapeutics Major Business
    • 2.13.3 Qyuns Therapeutics IL-23 Receptor Antagonist Product and Services
    • 2.13.4 Qyuns Therapeutics IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Qyuns Therapeutics Recent Developments/Updates
  • 2.14 Bio-Thera Solutions
    • 2.14.1 Bio-Thera Solutions Details
    • 2.14.2 Bio-Thera Solutions Major Business
    • 2.14.3 Bio-Thera Solutions IL-23 Receptor Antagonist Product and Services
    • 2.14.4 Bio-Thera Solutions IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Bio-Thera Solutions Recent Developments/Updates
  • 2.15 Huadong Medicine
    • 2.15.1 Huadong Medicine Details
    • 2.15.2 Huadong Medicine Major Business
    • 2.15.3 Huadong Medicine IL-23 Receptor Antagonist Product and Services
    • 2.15.4 Huadong Medicine IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Huadong Medicine Recent Developments/Updates

3 Competitive Environment: IL-23 Receptor Antagonist by Manufacturer

  • 3.1 Global IL-23 Receptor Antagonist Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global IL-23 Receptor Antagonist Revenue by Manufacturer (2021-2026)
  • 3.3 Global IL-23 Receptor Antagonist Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of IL-23 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 IL-23 Receptor Antagonist Manufacturer Market Share in 2025
    • 3.4.3 Top 6 IL-23 Receptor Antagonist Manufacturer Market Share in 2025
  • 3.5 IL-23 Receptor Antagonist Market: Overall Company Footprint Analysis
    • 3.5.1 IL-23 Receptor Antagonist Market: Region Footprint
    • 3.5.2 IL-23 Receptor Antagonist Market: Company Product Type Footprint
    • 3.5.3 IL-23 Receptor Antagonist Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global IL-23 Receptor Antagonist Market Size by Region
    • 4.1.1 Global IL-23 Receptor Antagonist Sales Quantity by Region (2021-2032)
    • 4.1.2 Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2032)
    • 4.1.3 Global IL-23 Receptor Antagonist Average Price by Region (2021-2032)
  • 4.2 North America IL-23 Receptor Antagonist Consumption Value (2021-2032)
  • 4.3 Europe IL-23 Receptor Antagonist Consumption Value (2021-2032)
  • 4.4 Asia-Pacific IL-23 Receptor Antagonist Consumption Value (2021-2032)
  • 4.5 South America IL-23 Receptor Antagonist Consumption Value (2021-2032)
  • 4.6 Middle East & Africa IL-23 Receptor Antagonist Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
  • 5.2 Global IL-23 Receptor Antagonist Consumption Value by Type (2021-2032)
  • 5.3 Global IL-23 Receptor Antagonist Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
  • 6.2 Global IL-23 Receptor Antagonist Consumption Value by Application (2021-2032)
  • 6.3 Global IL-23 Receptor Antagonist Average Price by Application (2021-2032)

7 North America

  • 7.1 North America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
  • 7.2 North America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
  • 7.3 North America IL-23 Receptor Antagonist Market Size by Country
    • 7.3.1 North America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
    • 7.3.2 North America IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
  • 8.2 Europe IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
  • 8.3 Europe IL-23 Receptor Antagonist Market Size by Country
    • 8.3.1 Europe IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific IL-23 Receptor Antagonist Market Size by Region
    • 9.3.1 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
  • 10.2 South America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
  • 10.3 South America IL-23 Receptor Antagonist Market Size by Country
    • 10.3.1 South America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
    • 10.3.2 South America IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa IL-23 Receptor Antagonist Market Size by Country
    • 11.3.1 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 IL-23 Receptor Antagonist Market Drivers
  • 12.2 IL-23 Receptor Antagonist Market Restraints
  • 12.3 IL-23 Receptor Antagonist Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of IL-23 Receptor Antagonist and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of IL-23 Receptor Antagonist
  • 13.3 IL-23 Receptor Antagonist Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 IL-23 Receptor Antagonist Typical Distributors
  • 14.3 IL-23 Receptor Antagonist Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on IL-23 Receptor Antagonist. Industry analysis & Market Report on IL-23 Receptor Antagonist is a syndicated market report, published as Global IL-23 Receptor Antagonist Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of IL-23 Receptor Antagonist market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo